CountryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua & BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia & HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCentral African RepublicChadChileChinaColombiaComorosCongoCongo Democratic RepublicCosta RicaCote d'IvoireCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEast TimorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFijiFinlandFranceGabonGambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKorea NorthKorea SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalThe NetherlandsNew ZealandNicaraguaNigerNigeriaNorwayOmanPakistanPalauPalestinian State*PanamaPapua New GuineaParaguayPeruThe PhilippinesPolandPortugalQatarRomaniaRussiaRwandaSt. Kitts & NevisSt. LuciaSt. Vincent & The GrenadinesSamoaSan MarinoSao Tome & PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth SudanSpainSri LankaSudanSurinameSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad & TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States of AmericaUruguayUzbekistanVanuatuVatican City (Holy See)VenezuelaVietnamYemenZambiaZimbabwe
Multi User License - $2,500
Smart inhalers are a type of advanced inhaler that can be digitally connected to apps on a phone or tablet, allowing doctors to better manage a patient’s respiratory condition. Smart inhalers use Bluetooth technology to detect inhaler use, remind patients to take their medication, and collect data to aid in care planning.
The India Smart Inhalers Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
The launch of “ADHERO,” a new linked smart gadget for metered-dose inhalers, was announced by pharma giant Lupin Limited (Lupin). This one-of-a-kind device is meant to help patients with chronic respiratory disorders keep track of their MDI usage and enhance therapeutic adherence. Reusable device with built-in sensors to monitor daily usage and consumption habits.App for MyAdhero uses Bluetooth to connect the gadget to smartphones, allowing patients to view information and create reminders. Physicians may use the app to track patient adherence to medicine, which can help them improve clinical outcomes.
Glenmark Pharmaceuticals Limited, a research-driven worldwide integrated pharmaceutical firm, announced the debut of India’s first Digital Dose Inhaler for patients with asthma and pulmonary disease. Asthma and chronic obstructive pulmonary disease (COPD) sufferers can track adherence to their therapy with the Digihaler inhaler, which features an accurate digital dose counter and a low dose warning indicator.
Aptar Pharma has introduced a novel connected gadget that has the potential to transform traditional metered dose inhalers into smart connected devices. HeroTracker Sense was created to aid patients suffering from chronic respiratory disorders caused by COVID-19, such as asthma, COPD, cystic fibrosis, and other respiratory conditions, by supporting proper inhalation technique and adherence.
© Copyright 2017-2022. Mobility Foresights. All Rights Reserved.